Inventor · disambiguated record
Dong Liu
Also filed as: LIU DONG · Liu dong-xu
39 granted patents·22 pending applications·148 citations·filing 2003–2024
96Inventor score
Files withJIANGSU HENGRUI MEDICINE CO9KIND PHARMACEUTICAL6ETERNITY BIOSCIENCE INC5NIU DEQIANG5SUN YING5
Top patents by PatentIndex Score
61 records- 0197US7605126B2Acylaminoheteroaryl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Oct 20, 2009·38 cites·15 claims
- 0297US7582605B2Phosphorus-containing hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Sep 1, 2009·59 cites·9 claims
- 0390US10300018B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2016·Granted May 28, 2019·4 cites·29 claims
- 0487US11737982B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2019·Granted Aug 29, 2023·2 cites·4 claims
- 0586US11655249B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2021·Granted May 23, 2023·2 cites·22 claims
- 0686US9951077B2Aminopyridazinone compounds as protein kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Apr 24, 2018·9 cites·3 claims
- 0786US9862764B2Compositions and methods for antibodies targeting BMP6CONG FENG·Filed 2015·Granted Jan 9, 2018·8 cites·54 claims
- 0884US10323037B2Aminopyridazinone compounds as protein kinase inhibitorsJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 18, 2019·4 cites·31 claims
- 0983US8211891B2Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitorsGAI YONGHUA·Filed 2009·Granted Jul 3, 2012·4 cites·188 claims
- 1082US12311055B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2023·Granted May 27, 2025·0 cites·19 claims
- 1182US10683346B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2017·Granted Jun 16, 2020·2 cites·20 claims
- 1281US10759787B2Benzofuran derivative, preparation method thereof and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Sep 1, 2020·2 cites·23 claims
- 1381US9090568B2Quinazolinediones and their useLIU DONG·Filed 2012·Granted Jul 28, 2015·6 cites·16 claims
- 1478US11512055B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Nov 29, 2022·1 cites·2 claims
- 1576US11970495B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2023·Granted Apr 30, 2024·0 cites·12 claims
- 1676US11945817B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
- 1775US11021478B2Indolizine derivatives and their application in medicineKIND PHARMACEUTICAL·Filed 2018·Granted Jun 1, 2021·2 cites·15 claims
- 1875US8501681B2Macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 6, 2013·2 cites·15 claims
- 1973US11535633B2Fused tricyclic heterocycle compounds and therapeutic uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 2072US11434269B2Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)NOVARTIS AG·Filed 2017·Granted Sep 6, 2022·1 cites·25 claims
- 2170US12187684B2Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Jan 7, 2025·0 cites·18 claims
- 2268US11718615B2Heterocyclic compounds and their application in medicineKIND PHARMACEUTICAL·Filed 2021·Granted Aug 8, 2023·0 cites·17 claims
- 2367US11059811B2Benzofuran derivative, preparation method thereof and use thereof in medicineJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 2467US2021018504A1Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapyMA RUNLIN Z·Filed 2019·Application pending·0 cites
- 2566US8003777B2Use of untranslated region of osmotin gene to enhance transgene expression in plantsDOW AGROSCIENCES LLC·Filed 2008·Granted Aug 23, 2011·0 cites·8 claims
- 2665US11530261B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·30 claims
- 2764US12151999B2Small molecule compounds having naphthylamine structure and application thereofHANGZHOU PHECDAMED CO LTD·Filed 2024·Granted Nov 26, 2024·0 cites·13 claims
- 2860US8785377B2Tetrazolyl macrocyclic hepatitis C serine protease inhibitorsSUN YING·Filed 2008·Granted Jul 22, 2014·0 cites·18 claims
- 2960US2025362302A1Intracellular ligation of photocatalysts for photo-responsive, probe-mediated protein labelingSEED THERAPEUTICS US INC·Filed 2023·Application pending·0 cites
- 3060US2009098085A1Tetrazolyl acyclic hepatitis c serine protease inhibitorsSUN YING·Filed 2008·Application pending·0 cites
- 3159US2009005387A1Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 3258US2017010267A1Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapyMA RUNLIN Z·Filed 2013·Application pending·0 cites
- 3358US2009035271A1Tetrazolyl macrocyclic hepatitis c serine protease inhibitorsSUN YING·Filed 2007·Application pending·0 cites
- 3457US9309279B2Macrocyclic hepatitis C serine protease inhibitorsABBVIE INC·Filed 2014·Granted Apr 12, 2016·0 cites·17 claims
- 3557US8008466B2Use of untranslated region of osmotin gene to enhance transgene expression in plantsDOW AGROSCIENCES LLC·Filed 2006·Granted Aug 30, 2011·0 cites·8 claims
- 3657US2005102713A1Use of untranslated region of osmotin gene to enhance transgene expression in plantsFiled 2003·Application pending·0 cites
- 3756US8809264B2Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 19, 2014·0 cites·15 claims
- 3856US2024327340A1Small molecule compounds having naphthylamine structure and application thereofHANGZHOU PHECDAMED CO LTD·Filed 2022·Application pending·0 cites
- 3954US8426360B2Carbocyclic oxime hepatitis C virus serine protease inhibitorsLIU DONG·Filed 2008·Granted Apr 23, 2013·0 cites·18 claims
- 4054US8283309B2Bridged carbocyclic oxime hepatitis C virus serine protease inhibitorsLIU DONG·Filed 2008·Granted Oct 9, 2012·0 cites·14 claims
- 4154US2025333377A1Solid form of naphthylamine mitophagy inducer, and preparation method therefor, pharmaceutical composition thereof and use thereofHANGZHOU PHECDAMED CO LTD·Filed 2024·Application pending·0 cites
- 4252US11732234B1Use of diatom in rice planting and cultivation method of rice in symbiosis with diatomUNIV JIANGXI AGRICULTURAL·Filed 2022·Granted Aug 22, 2023·0 cites·5 claims
- 4352US11236088B2Heterocyclic compounds and their application in medicineKIND PHARMACEUTICAL·Filed 2018·Granted Feb 1, 2022·0 cites·18 claims
- 4452US8962551B2Quinoxalinyl derivativesNIU DEQIANG·Filed 2008·Granted Feb 24, 2015·0 cites·15 claims
- 4551US8304385B2Macrocyclic tetrazolyl hepatitis C serine protease inhibitorsSUN YING·Filed 2008·Granted Nov 6, 2012·0 cites·14 claims
- 4650US2022169645A1Compounds as bruton tyrosine kinase inhibitors, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 4749US9249433B2Clostridium acetobutylicum and application thereofYING HANJIE·Filed 2012·Granted Feb 2, 2016·0 cites·21 claims
- 4849US2022009909A1Adamts inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 4949US2024299360A1Adamts inhibitors, preparation methods and medicinal uses thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 5048US2020277278A1Deuterium Atom-Substituted Indole Formamide Derivative, Preparation Method Therefor, and Medical Applications ThereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dong Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →